Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling
- PMID: 33858992
- DOI: 10.1126/science.abf7958
Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling
Abstract
Obesity is a global epidemic that causes morbidity and impaired quality of life. The melanocortin receptor 4 (MC4R) is at the crux of appetite, energy homeostasis, and body-weight control in the central nervous system and is a prime target for anti-obesity drugs. Here, we present the cryo-electron microscopy (cryo-EM) structure of the human MC4R-Gs signaling complex bound to the agonist setmelanotide, a cyclic peptide recently approved for the treatment of obesity. The work reveals the mechanism of MC4R activation, highlighting a molecular switch that initiates satiation signaling. In addition, our findings indicate that calcium (Ca2+) is required for agonist, but not antagonist, efficacy. These results fill a gap in the understanding of MC4R activation and could guide the design of future weight-management drugs.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Comment in
-
Putting a brake on hunger.Science. 2021 May 21;372(6544):792-793. doi: 10.1126/science.abi8942. Science. 2021. PMID: 34016769 No abstract available.
Similar articles
-
Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.ACS Chem Neurosci. 2019 Mar 20;10(3):1055-1065. doi: 10.1021/acschemneuro.8b00346. Epub 2018 Aug 13. ACS Chem Neurosci. 2019. PMID: 30048591 Free PMC article.
-
Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.Life Sci. 2022 Oct 15;307:120857. doi: 10.1016/j.lfs.2022.120857. Epub 2022 Aug 2. Life Sci. 2022. PMID: 35931197
-
Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.J Med Chem. 2006 Jul 13;49(14):4035-43. doi: 10.1021/jm058241a. J Med Chem. 2006. PMID: 16821763 Review. No abstract available.
-
Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.Cell Res. 2021 Nov;31(11):1176-1189. doi: 10.1038/s41422-021-00569-8. Epub 2021 Sep 24. Cell Res. 2021. PMID: 34561620 Free PMC article.
-
Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.Int J Mol Sci. 2020 Aug 10;21(16):5728. doi: 10.3390/ijms21165728. Int J Mol Sci. 2020. PMID: 32785054 Free PMC article. Review.
Cited by
-
Evolutionary Identification of the Requirement of the Second Intracellular Loop for the Constitutive Activity of Melanocortin-4 Receptors.ACS Pharmacol Transl Sci. 2024 Feb 15;7(3):630-640. doi: 10.1021/acsptsci.3c00169. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481681
-
Development of Melanocortin 4 Receptor Agonists by Exploiting Animal-Derived Macrocyclic, Disulfide-Rich Peptide Scaffolds.ACS Pharmacol Transl Sci. 2023 Sep 26;6(10):1373-1381. doi: 10.1021/acsptsci.3c00090. eCollection 2023 Oct 13. ACS Pharmacol Transl Sci. 2023. PMID: 37854631
-
Lipocalin 2 receptors: facts, fictions, and myths.Front Immunol. 2023 Aug 11;14:1229885. doi: 10.3389/fimmu.2023.1229885. eCollection 2023. Front Immunol. 2023. PMID: 37638032 Free PMC article. Review.
-
Competition between stochastic neuropeptide signals calibrates the rate of satiation.Res Sq [Preprint]. 2023 Jul 26:rs.3.rs-3185572. doi: 10.21203/rs.3.rs-3185572/v1. Res Sq. 2023. PMID: 37546985 Free PMC article. Preprint.
-
Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors.Cell Discov. 2023 Jul 31;9(1):81. doi: 10.1038/s41421-023-00586-4. Cell Discov. 2023. PMID: 37524700 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
